Dr. Jerry L. Nadler

• 
  www.vabio.org/combination-drug-therapy-may-hold-the-key - [Cached Version]
  Published on: 5/11/2008    Last Visited: 5/11/2008  

  Jerry Nadler and Sarah Tersey and conducted at the University of Virginia.
  ...
  "We are very encouraged by the results of this study and others that indicate LSF in combination with certain peptides, or small molecules, is a potential therapy for the reversal of type 1 diabetes," said Dr. Nadler, chief science officer of DiaKine.

• 
  www.tocurediabetes.org/press.aspx?pressid=17 - [Cached Version]
  Published on: 4/6/2006    Last Visited: 8/13/2008  

  Dr. Jerry Nadler, chief of the UVa Division of Endocrinology and Metabolism, and colleagues theorized that simultaneously blocking a biological pathway that damages beta cells in the pancreas, while adding a growth-promoting stimulus for beta cells, might provide the critical ability to reverse type 1 diabetes.
  
  "This finding is very exciting because it one day may provide an opportunity to restore insulin-producing cells in people with type 1 diabetes without the need for toxic anti-rejection medications," Nadler said.

• 
  www.eurekalert.org/pub_releases/2008-06/evms-udc061008. - [Cached Version]
  Published on: 6/10/2008    Last Visited: 6/11/2008  

  The study tested the combination of Lisofylline (LSF), a drug that is being developed to halt immune damage to insulin producing cells, and Islet Neogenesis Associated Protein peptide (INGAP), a drug based on a naturally occurring protein produced by the pancreas. (ADA abstract number: 1620-P Unique Drug Combination for Reversal of Type 1 Diabetes, by Tersey, Carter, Kropf, Rosenberg, Nadler, available online at http://scientificsessions.diabetes.org)
  
  The study was conducted at the University of Virginia by a team of scientists led by Jerry L. Nadler, M.D.Currently Director of Endocrinology and Metabolism at the University of Virginia, Nadler will join the faculty at Eastern Virginia Medical School (EVMS) in July as chair of the Department of Internal Medicine and head of the EVMS Strelitz Diabetes Center.
  ...
  "These are very encouraging results," Nadler said."Since both LSF and INGAP are already known to be safe, we should soon be able to begin testing the combination of LSF and INGAP in the clinic as a potential therapy for Type 1 diabetes in people soon."
  
  Nadler was recruited to EVMS as part of a strategic initiative to expand the medical school's research capabilities in four areas where the state's eastern region has specific health needs and EVMS has existing research strengths, including: diabetes, cardiovascular disease, women's health/infant development, and cancer.
  ...
  Nadler's work with LSF and INGAP is exactly the kind of innovative new therapy that we want to bring to fruition.
  ...
  Dr. Nadler is DiaKine's Chief Scientific Officer.

• 
  www.eatqod.com/forum/viewtopic.php?f=8&t=58&sid=70c3d4b - [Cached Version]
  Published on: 12/2/2007    Last Visited: 4/1/2009  

  Dr. Jerry Nadler, Chief of Endocrinology and Metabolism at the University of Virginia, reports that a low dietary intake of magnesium can also encourage insulin resistance.
  
  In his study, Nadler placed patients on a magnesium deficient diet for a mere three weeks. This showed that their cells not only became deficient in magnesium, but also that insulin became less capable of transporting glucose from the blood into cells.
  
  Dr. Nadler's message was quite clear, "You can cause insulin resistance in people who do not have diabetes.

• 
  www.innovationsreport.com/html/reports/life_sciences/re - [Cached Version]
  Published on: 9/11/2007    Last Visited: 11/13/2007  

  "This research is exciting because it advances our knowledge of a new gene that is involved in causing Type 1 diabetes and could pave the way for new treatments to prevent or reverse this increasingly prevalent disease," said Dr. Jerry L. Nadler, who is chief of the UVa Division of Endocrinology and Metabolism.

• 
  ihub.org/forum/showthread.php?s=0fc0ef3eac7208393efbb09 - [Cached Version]
  Published on: 10/29/2007    Last Visited: 11/29/2007  

  "This research is exciting because it advances our knowledge of a new gene that is involved in causing Type 1 diabetes and could pave the way for new treatments to prevent or reverse this increasingly prevalent disease," said Dr. Jerry L. Nadler, who is chief of the UVa Division of Endocrinology and me.tabolism.

• 
  www.virginiabusiness.com/index.php/people/article/peopl - [Cached Version]
  Published on: 6/24/2008    Last Visited: 6/24/2008  

  Dr. Jerry Nadler, named chairman of the internal medicine department at Eastern Virginia Medical School in Norfolk.Nadler had chaired the endocrinology and metabolism department at the University of Virginia Medical School.He will work to recruit top talent to EVMS to develop nationally competitive research operations.That $8 million

• 
  silverbulletin.utopiasilver.com/index.php?option=com_co - [Cached Version]
  Last Visited: 6/1/2009  

  When Dr. Jerry Nadler of the Gonda Diabetes Center at the City of Hope Medical Center in Duarte, California, and his colleagues placed 16 healthy people on magnesium-deficient diets, their insulin became less effective at getting sugar from their blood into their cells, where it's burned or stored as fuel.

• 
  diabetes.coh.org/team_nadler.htm - [Cached Version]
  Published on: 1/12/2001    Last Visited: 1/12/2001  

  Jerry L. Nadler, M.DDirectorPhone : (626) 359-8111 ext. 2690Fax : (626) 301-8489E-mail : jnadler@coh.org
  
  ...
  Meet our Team - Dr. Nadler
  
  ...
  Jerry L. Nadler, M.DDirectorPhone : (626) 359-8111 ext. 2690Fax : (626) 301-8489E-mail : jnadler@coh.org

• 
  www.cavalierdaily.com/news.asp?pid=1700 - [Cached Version]
  Published on: 3/13/2008    Last Visited: 3/14/2008  

  Jerry Nadler, currently chief of the University's endocrinology and metabolism department, will be leaving the University in June to fill a position at Eastern Virginia Medical School.According to ...

Page:  1 2 3 4 5